Founder and CEO
Appears in 1 story
Last updated Nov 5, 2026
Founder and CEO; beneficially owns 21.5% of Bambusa
Bambusa Therapeutics priced an upsized Nasdaq IPO on Oct. 29, raising $168.9 million. It sold 10.56 million shares at $16 each, up from 9.38 million, and began trading under BBTX on Oct. 30.
Updated 6 days ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
